Lantheus Holdings Inc.

Lantheus Holdings, Inc. delivers radiopharmaceuticals and imaging agents for cardiovascular, oncology, and neurodegenerative diseases, including DEFINITY, PYLARIFY, and AI‑driven Bone Scan Index. Its portfolio of diagnostics, therapies, and AI tools is supported by partnerships.

Headquarters: United States (USA)

Website: Visit Site 🔗
Type: Corporation

Company Profile

Sector: Hospitals and Health Care
Industry: Medical and Diagnostic Laboratories

Employees: 808
HQ: Bedford

Unlock the full potential.

Get access to Relative P/E Ratio Valuation Histogram.

Upgrade

Traded Instruments

+ Add Instrument 1

Symbol	Name	Type	Exchange	Currency	ISIN	Status	Actions
LNTH	Lantheus Holdings Inc. Cap: 4.6B \| P/E: 28.0	EQUITY	NMS	USD	US5165441032	Active	📈